256 related articles for article (PubMed ID: 15361348)
1. [Lysophosphatidic acid: a "bioactive" phospholipid].
Saulnier-Blache JS
Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
3. Potential role of lysophosphatidic acid in hypertension and atherosclerosis.
Xu YJ; Aziz OA; Bhugra P; Arneja AS; Mendis MR; Dhalla NS
Can J Cardiol; 2003 Dec; 19(13):1525-36. PubMed ID: 14760444
[TBL] [Abstract][Full Text] [Related]
4. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.
Panchatcharam M; Miriyala S; Yang F; Rojas M; End C; Vallant C; Dong A; Lynch K; Chun J; Morris AJ; Smyth SS
Circ Res; 2008 Sep; 103(6):662-70. PubMed ID: 18703779
[TBL] [Abstract][Full Text] [Related]
6. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
7. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
[TBL] [Abstract][Full Text] [Related]
9. Two pathways for lysophosphatidic acid production.
Aoki J; Inoue A; Okudaira S
Biochim Biophys Acta; 2008 Sep; 1781(9):513-8. PubMed ID: 18621144
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors.
Shiono S; Kawamoto K; Yoshida N; Kondo T; Inagami T
Biochem Biophys Res Commun; 1993 Jun; 193(2):667-73. PubMed ID: 8390248
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.
Murph MM; Scaccia LA; Volpicelli LA; Radhakrishna H
J Cell Sci; 2003 May; 116(Pt 10):1969-80. PubMed ID: 12668728
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of lysophosphatidic acid in cancer.
Mills GB; Moolenaar WH
Nat Rev Cancer; 2003 Aug; 3(8):582-91. PubMed ID: 12894246
[TBL] [Abstract][Full Text] [Related]
14. The role of lysophosphatidic acid in the physiology and pathology of the skin.
Lei L; Su J; Chen J; Chen W; Chen X; Peng C
Life Sci; 2019 Mar; 220():194-200. PubMed ID: 30584899
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid synthesis and release.
Pagès C; Simon MF; Valet P; Saulnier-Blache JS
Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):1-10. PubMed ID: 11324699
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
[TBL] [Abstract][Full Text] [Related]
17. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
Saulnier-Blache JS
J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
[TBL] [Abstract][Full Text] [Related]
18. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid, a simple phospholipid with myriad functions.
Yanagida K; Shimizu T
Pharmacol Ther; 2023 Jun; 246():108421. PubMed ID: 37080433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]